What is PACIFIC HLTH CRE ORGZ INC's earnings per share (EPS)?

PACIFIC HLTH CRE ORGZ INC (PFHO) reported diluted earnings per share of $0.11 for fiscal year 2025. This represents a 57.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PACIFIC HLTH CRE ORGZ INC (PFHO) Financials

PFHO

Trailing 12 months to June 30, 2026

Revenue $6.4M -3.4% YoY

Net Income $979K -30.1% YoY

EPS (Diluted) $0.09 -10.0% YoY

Free Cash Flow $578K -55.7% YoY

Market Cap $12.0M as of Oct 2, 2026

Price / Sales 1.9x on $6.4M revenue, trailing 12 months to June 30, 2026

Price / Earnings 12.3x on $979K net income, trailing 12 months to June 30, 2026

Price / Book 0.9x on $13.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PFHO SEC filings page.

PACIFIC HLTH CRE ORGZ INC (PFHO) reported $6.4M in revenue over the twelve months to Jun 30, 2026, down 3.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PFHO FY2025 2026-10-03

Pacific Health Care is a cash-generating, lightly financed business whose recent growth has improved operating profitability without heavy reinvestment.

Across FY2022-FY2025, operating cash flow and net income broadly agreed: cash flow exceeded profit in two years and remained close in the other two, while free cash flow stayed positive throughout. That earnings-to-cash agreement suggests reported profit is generally not being absorbed by working capital.

In FY2025, free cash flow of $1.14M nearly matched operating cash flow of $1.16M, indicating that operating activity converted into cash efficiently. Capital expenditures were only $23K, so little cash was required for reported physical reinvestment.

Operating margin widened from 12.1% in FY2023 to 14.9% in FY2025 while revenue also moved higher, indicating that incremental sales reached profit more efficiently; the figures support improved cost absorption, not a proven pricing explanation. Liabilities fell from $746K to $389K, and a 34.5x current ratio with near-zero debt-to-equity indicates growth is being funded mainly through internal resources rather than borrowing.

Financial Health Signals

Financial health score not available

PACIFIC HLTH CRE ORGZ INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Safe

21.80

PACIFIC HLTH CRE ORGZ INC scores 21.80, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($12.0M) relative to total liabilities ($389K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/7

PACIFIC HLTH CRE ORGZ INC passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.84x

For every $1 of reported earnings, PACIFIC HLTH CRE ORGZ INC generates $0.84 in operating cash flow ($1.2M OCF vs $1.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe

657.71x

PACIFIC HLTH CRE ORGZ INC earns $657.71 in operating income for every $1 of interest expense ($1.0M vs $2K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.8M

YoY+2.8%

QoQ+18.5%

5Y CAGR+5.7%

10Y CAGR+3.6%

PACIFIC HLTH CRE ORGZ INC generated $1.8M in revenue in Q2 2026. This represents an increase of 2.8% from the same quarter a year earlier. Against the prior quarter it is up 18.5%.

EBITDA

$375K

YoY+21.0%

QoQ+110.5%

5Y CAGR+21.4%

10Y CAGR+9.5%

PACIFIC HLTH CRE ORGZ INC's EBITDA was $375K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 21.0% from the same quarter a year earlier. Against the prior quarter it is up 110.5%.

Net Income

$327K

YoY-48.7%

QoQ+68.8%

5Y CAGR+28.1%

10Y CAGR+15.7%

PACIFIC HLTH CRE ORGZ INC reported $327K in net income in Q2 2026. This represents a decrease of 48.7% from the same quarter a year earlier. Against the prior quarter it is up 68.8%.

EPS (Diluted)

$0.03

YoY-40.0%

QoQ+50.0%

5Y CAGR+24.6%

PACIFIC HLTH CRE ORGZ INC earned $0.03 per diluted share (EPS) in Q2 2026. This represents a decrease of 40.0% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.

Cash & Balance Sheet

Free Cash Flow

-$10K

YoY-102.1%

QoQ-104.3%

PACIFIC HLTH CRE ORGZ INC recorded an outflow of $10K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 102.1% from the same quarter a year earlier. Against the prior quarter it is down 104.3%.

Cash & Debt

$2.2M

YoY+3.9%

QoQ-6.6%

5Y CAGR-26.0%

10Y CAGR-6.7%

PACIFIC HLTH CRE ORGZ INC held $2.2M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

13M

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR+32.0%

PACIFIC HLTH CRE ORGZ INC had 13M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Operating Margin

20.8%

YoY+3.2pp

QoQ+9.3pp

5Y change+11.0pp

10Y change+10.4pp

PACIFIC HLTH CRE ORGZ INC's operating margin was 20.8% in Q2 2026, reflecting core business profitability. This is up 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.3 percentage points.

Net Margin

18.4%

YoY-18.5pp

QoQ+5.5pp

5Y change+11.4pp

10Y change+12.3pp

PACIFIC HLTH CRE ORGZ INC's net profit margin was 18.4% in Q2 2026, showing the share of revenue converted to profit. This is down 18.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.5 percentage points.

Return on Equity

2.4%

YoY-2.6pp

QoQ+0.9pp

5Y change+1.5pp

10Y change+1.0pp

PACIFIC HLTH CRE ORGZ INC's ROE was 2.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$5K

5Y CAGR+15.5%

10Y CAGR-6.4%

PACIFIC HLTH CRE ORGZ INC invested $5K in capex in Q2 2026, funding long-term assets and infrastructure.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

PFHO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PFHO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$6.4M	$6.7M+10.7%	$6.1M+7.7%	$5.6M-2.0%	$5.7M+6.3%	$5.4M-10.6%	$6.0M-17.6%	$7.3M+7.9%	$6.8M+4.5%	$6.5M+14.4%	$5.7M-30.8%	$8.2M-13.1%	$9.5M+44.0%	$6.6M+36.2%	$4.8M+70.4%	$2.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$513K-5.6%	$543K	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$6.3M+5.4%	$6.0M	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$742K	$767K+5.6%	$726K+17.7%	$617K-12.6%	$706K+7.2%	$658K-5.4%	$696K-14.8%	$817K+11.1%	$735K+12.5%	$653K-1.2%	$661K+3.7%	$638K+10.5%	$577K+21.6%	$475K-3.2%	$491K+25.0%	$392K
Operating Income	$925K	$1.0M+17.4%	$853K+25.7%	$679K+1.9%	$666K+29.0%	$516K-37.0%	$820K-51.2%	$1.7M-11.1%	$1.9M+12.0%	$1.7M+74.1%	$969K-65.7%	$2.8M-14.4%	$3.3M+60.4%	$2.1M+66.7%	$1.2M+282.6%	$322K
EBITDA	N/A	$1.0M+15.6%	$887K+23.8%	$716K+2.3%	$700K+23.8%	$565K-35.4%	$876K-50.1%	$1.8M-10.2%	$2.0M+11.0%	$1.8M+67.3%	$1.1M-63.5%	$2.9M-13.6%	$3.3M+59.4%	$2.1M+66.3%	$1.3M+275.8%	$336K
Interest Expense	$0	$2K-57.2%	$4K	$0	$0+100.0%	-$5K	$0	N/A	$0	$0	$0-100.0%	$202-82.4%	$1K-39.8%	$2K+1.3%	$2K+58.1%	$1K
Income Tax	$345K	$507K+33.4%	$380K+18.6%	$321K+59.9%	$200K-0.3%	$201K-25.7%	$271K-43.8%	$482K-9.0%	$530K-26.7%	$723K+79.6%	$403K-64.8%	$1.1M-14.2%	$1.3M+62.5%	$821K+57.3%	$522K+326.2%	$122K
Net Income	$979K	$1.4M+57.0%	$884K+15.1%	$768K+55.8%	$493K-50.5%	$995K+81.1%	$550K-54.1%	$1.2M-11.9%	$1.4M+41.0%	$964K+70.2%	$567K-66.2%	$1.7M-14.5%	$2.0M+59.2%	$1.2M+73.3%	$711K+258.9%	$198K
EPS (Basic)	N/A	$0.11+57.1%	$0.07+16.7%	$0.06+50.0%	$0.04-50.0%	$0.08+100.0%	$0.04-55.6%	$0.09-18.2%	$0.11-63.3%	$0.30-57.7%	$0.71-66.2%	$2.10-14.3%	$2.45+59.1%	$1.54+73.0%	$0.89+256.0%	$0.25
EPS (Diluted)	$0.09	$0.11+57.1%	$0.07+16.7%	$0.06+50.0%	$0.04-50.0%	$0.08+100.0%	$0.04-55.6%	$0.09	$0.11	$0.30	$0.71-66.2%	$2.10-14.3%	$2.45+59.1%	$1.54+73.0%	$0.89+256.0%	$0.25
Diluted Shares (Avg)	N/A	13M0.0%	13M0.0%	13M0.0%	13M0.0%	13M0.0%	13M0.0%	13M	13M	3M	801,000+0.1%	800,0000.0%	800,396-0.3%	802,4240.0%	802,4240.0%	802,424

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.8M+2.8%	$1.5M-17.7%	$1.6M-2.6%	$1.6M+5.7%	$1.7M+12.0%	$1.8M+30.1%	$1.6M+2.4%	$1.5M+6.8%
SG&A Expenses	$187K-9.1%	$181K-3.6%	$187K-4.5%	$186K+1.9%	$206K+1.9%	$188K+29.1%	$196K-13.5%	$183K+8.5%
Operating Income	$369K+21.7%	$173K-45.1%	$178K-46.7%	$205K+35.3%	$304K+58.1%	$314K+79.5%	$334K+9.8%	$152K+3.1%
EBITDA	$375K+21.0%	$178K-44.7%	$184K-46.2%	$210K+31.4%	$310K+54.0%	$322K+74.2%	$341K+8.7%	$160K+2.6%
Interest Expense	$0	$0-100.0%	$0-100.0%	$0	$0	$2K	$4K	$0
Income Tax	$137K-47.2%	$74K-34.9%	$47K-63.4%	$87K-3.6%	$259K+210.1%	$114K+48.0%	$129K-1.0%	$90K+29.3%
Net Income	$327K-48.7%	$194K-33.8%	$235K-20.5%	$223K+27.5%	$637K+195.5%	$293K+48.3%	$296K+5.2%	$175K-2.4%
EPS (Basic)	$0.03-40.0%	$0.020.0%	$0.020.0%	$0.02+100.0%	$0.05+150.0%	$0.020.0%	$0.020.0%	$0.010.0%
EPS (Diluted)	$0.03-40.0%	$0.02	$0.020.0%	$0.02	$0.05+150.0%	$0.020.0%	$0.020.0%	$0.010.0%
Diluted Shares (Avg)	13M0.0%	13M	N/A	13M	13M0.0%	13M0.0%	N/A	13M0.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

PFHO Balance Sheet

PFHO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$13.5M+8.3%	$12.4M+5.8%	$11.8M-2.5%	$12.1M+6.3%	$11.3M+2.0%	$11.1M+8.3%	$10.3M+20.6%	$8.5M+17.2%	$7.3M+16.0%	$6.3M+13.4%	$5.5M+7.0%	$5.2M+69.9%	$3.0M+48.2%	$2.0M+93.4%	$1.1M
Current Assets	$13.4M+8.5%	$12.3M+6.6%	$11.6M-2.7%	$11.9M+6.8%	$11.1M+4.6%	$10.6M+11.6%	$9.5M+14.5%	$8.3M+18.0%	$7.1M+17.7%	$6.0M+15.0%	$5.2M+5.0%	$5.0M+71.4%	$2.9M+54.9%	$1.9M+91.0%	$980K
Cash & Equivalents	$2.2M+4.7%	$2.1M-17.0%	$2.5M+22.5%	$2.0M-79.8%	$10.1M+6.2%	$9.5M+17.2%	$8.1M+14.6%	$7.1M+21.6%	$5.8M+16.2%	$5.0M+30.5%	$3.8M+30.2%	$2.9M+132.8%	$1.3M+163.8%	$480K+30.2%	$368K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$1.0M-2.3%	$1.0M+0.8%	$1.0M+8.3%	$943K+1.6%	$928K-12.7%	$1.1M-4.6%	$1.1M+18.5%	$940K-9.7%	$1.0M+22.5%	$850K-18.3%	$1.0M-44.3%	$1.9M+23.0%	$1.5M+14.0%	$1.3M+154.4%	$524K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$389K-47.9%	$746K-21.4%	$948K+29.0%	$735K+44.6%	$508K-60.2%	$1.3M+31.2%	$974K+129.8%	$424K-21.3%	$539K+7.9%	$499K+29.7%	$385K-27.9%	$534K+79.6%	$297K-45.2%	$542K+105.5%	$264K
Current Liabilities	$389K-47.9%	$746K-20.4%	$936K+32.1%	$709K+41.4%	$501K-51.9%	$1.0M+52.9%	$682K+60.8%	$424K-21.3%	$539K+7.9%	$499K+29.7%	$385K-27.9%	$534K+84.6%	$289K-44.5%	$520K+102.8%	$257K
Non-Current Liabilities	$0	$0-100.0%	$12K-54.3%	$26K+266.2%	$7K-97.0%	$235K-19.6%	$292K	$0	$0	$0	$0	$0-100.0%	$8K-61.8%	$21K+201.7%	$7K
Total Equity	$13.1M+11.9%	$11.7M+8.2%	$10.8M-4.5%	$11.3M+4.6%	$10.8M+10.1%	$9.8M+5.9%	$9.3M+14.8%	$8.1M+20.2%	$6.7M+16.8%	$5.8M+12.2%	$5.1M+11.0%	$4.6M+68.8%	$2.7M+81.8%	$1.5M+89.4%	$796K
Retained Earnings	$12.6M+12.3%	$11.3M+8.5%	$10.4M-4.7%	$10.9M+4.7%	$10.4M+10.6%	$9.4M+6.2%	$8.9M+15.7%	$7.7M+21.6%	$6.3M+18.1%	$5.3M+11.9%	$4.8M+16.8%	$4.1M+92.7%	$2.1M+139.6%	$883K+415.0%	$171K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$14.1M+6.0%	$13.8M+8.8%	$13.5M+8.3%	$13.3M+9.5%	$13.3M+11.5%	$12.7M+5.1%	$12.4M+5.8%	$12.1M+7.3%
Current Assets	$14.0M+6.2%	$13.7M+9.0%	$13.4M+8.5%	$13.2M+9.5%	$13.2M+11.4%	$12.6M+5.4%	$12.3M+6.6%	$12.1M+7.5%
Cash & Equivalents	$2.2M+3.9%	$2.4M+1.7%	$2.2M+4.7%	$2.2M-14.4%	$2.2M-17.7%	$2.4M-17.0%	$2.1M-17.0%	$2.5M+7.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$1.3M+21.8%	$1.1M+14.3%	$1.0M-2.3%	$1.0M-6.9%	$1.1M+16.0%	$933K+6.2%	$1.0M+0.8%	$1.1M+31.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$516K-26.1%	$497K-26.7%	$389K-47.9%	$453K-39.3%	$698K-3.8%	$677K-34.8%	$746K-21.4%	$748K-5.6%
Current Liabilities	$516K-26.1%	$497K-26.7%	$389K-47.9%	$453K-39.3%	$698K-3.8%	$677K-34.0%	$746K-20.4%	$748K-3.7%
Non-Current Liabilities	$0	$0	$0	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%
Total Equity	$13.6M+7.8%	$13.3M+10.8%	$13.1M+11.9%	$12.8M+12.7%	$12.6M+12.5%	$12.0M+8.9%	$11.7M+8.2%	$11.4M+8.3%
Retained Earnings	$13.2M+8.0%	$12.8M+11.2%	$12.6M+12.3%	$12.4M+13.2%	$12.2M+13.0%	$11.6M+9.3%	$11.3M+8.5%	$11.0M+8.6%

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

PFHO Cash Flow Statement

PFHO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$598K	$1.2M+71.9%	$675K-27.6%	$932K+31.1%	$711K+84.1%	$386K-60.9%	$987K-9.5%	$1.1M-17.3%	$1.3M+59.7%	$826K-31.5%	$1.2M-44.3%	$2.2M+15.8%	$1.9M+131.5%	$808K+283.8%	$211K+138.9%	$88K
Depreciation & Amortization	N/A	$24K-29.7%	$34K-9.1%	$38K+10.4%	$34K-30.5%	$49K-11.8%	$55K-27.2%	$76K+13.5%	$67K-11.4%	$76K-10.6%	$85K+22.3%	$69K+40.8%	$49K+12.8%	$44K+48.9%	$29K+115.4%	$14K
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$49K	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	$19K	$23K+154.9%	$9K-47.9%	$18K-54.9%	$39K+111.5%	$18K-65.9%	$54K-9.0%	$59K+41.8%	$42K+150.4%	$17K-60.8%	$42K-73.2%	$158K+57.4%	$101K+3198.6%	$3K-96.5%	$88K+39.4%	$63K
Free Cash Flow	$578K	$1.1M+70.8%	$666K-27.2%	$915K+36.1%	$672K+82.7%	$368K-60.6%	$934K-9.5%	$1.0M-19.2%	$1.3M+57.8%	$809K-30.4%	$1.2M-42.0%	$2.0M+13.4%	$1.8M+119.9%	$805K+556.5%	$123K+389.5%	$25K
Investing Cash Flow	-$478K	-$990K+12.7%	-$1.1M-240.5%	$807K+109.2%	-$8.8M-47571.8%	-$18K+65.9%	-$54K+9.0%	-$59K-41.8%	-$42K-150.4%	-$17K+60.8%	-$42K+73.2%	-$158K-57.4%	-$101K-3198.6%	-$3K+97.6%	-$126K-100.3%	-$63K
Financing Cash Flow	-$36K	-$72K-304.8%	$35K+102.8%	-$1.3M	$0-100.0%	$219K-52.5%	$461K	$0+100.0%	-$20K	$0-100.0%	$7K+100.6%	-$1.1M-1145.0%	-$90K-365.9%	-$19K-171.6%	$27K+538.5%	-$6K
Dividends Paid	N/A	$37K	$0-100.0%	$1.3M	$0	N/A	N/A	$0-100.0%	$20K	$0-100.0%	$2K-99.8%	$934K	$0	$0	$0	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$177K+131.2%	$77K	$0	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$5K-101.2%	$228K-31.1%	$351K-38.2%	$24K+165.3%	$455K+409.0%	$331K+13.7%	$568K+13.4%	-$37K-122.2%
Depreciation & Amortization	$5K-14.2%	$5K-26.0%	$6K-21.9%	$5K-38.8%	$6K-33.0%	$7K-24.1%	$7K-27.4%	$8K-6.2%
Capital Expenditures	$5K	$0-100.0%	$14K+729.6%	$907-46.0%	$0-100.0%	$9K+127.0%	$2K-87.5%	$2K-36.6%
Free Cash Flow	-$10K-102.1%	$228K-29.2%	$337K-40.5%	$23K+160.1%	$455K+404.8%	$322K+12.2%	$566K+16.1%	-$38K-123.6%
Investing Cash Flow	-$152K+76.8%	$0+100.0%	-$325K+65.8%	-$907+46.0%	-$656K-268.1%	-$9K-127.0%	-$950K-222.6%	-$2K+36.6%
Financing Cash Flow	$0+100.0%	$0+100.0%	-$36K-2.7%	-$125+99.6%	-$625-100.6%	-$35K	-$35K+51.2%	-$35K+64.1%
Dividends Paid	N/A	N/A	$36K	$125	N/A	N/A	$0-100.0%	$0-100.0%

Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.

PFHO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PFHO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	92.5%+0.8pp	91.6%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	14.9%+0.9pp	14.1%+2.0pp	12.0%+0.5pp	11.6%+2.0pp	9.6%-4.0pp	13.6%-9.3pp	22.9%-4.9pp	27.8%+1.9pp	25.9%+8.9pp	17.0%-17.3pp	34.3%-0.5pp	34.8%+3.6pp	31.3%+5.7pp	25.6%+14.2pp	11.4%
Net Margin	20.7%+6.1pp	14.6%+0.9pp	13.6%+5.1pp	8.6%-9.8pp	18.4%+9.3pp	9.1%-7.2pp	16.3%-3.7pp	20.0%+5.2pp	14.8%+4.9pp	10.0%-10.4pp	20.4%-0.3pp	20.7%+2.0pp	18.8%+4.0pp	14.7%+7.7pp	7.0%
Return on Equity	10.6%+3.0pp	7.6%+0.5pp	7.1%+2.7pp	4.4%-4.8pp	9.2%+3.6pp	5.6%-7.3pp	12.9%-3.9pp	16.8%+2.5pp	14.3%+4.5pp	9.8%-22.8pp	32.7%-9.7pp	42.4%-2.6pp	45.0%-2.2pp	47.2%+22.3pp	24.9%
Return on Assets	10.3%+3.2pp	7.1%+0.6pp	6.5%+2.4pp	4.1%-4.7pp	8.8%+3.8pp	5.0%-6.7pp	11.7%-4.3pp	16.0%+2.7pp	13.3%+4.2pp	9.1%-21.3pp	30.4%-7.6pp	38.0%-2.6pp	40.6%+5.9pp	34.7%+16.0pp	18.7%
Current Ratio	34.45+17.9x	16.54+4.2x	12.36-4.4x	16.78-5.4x	22.23+12.0x	10.21-3.8x	14.00-5.7x	19.66+6.5x	13.12+1.1x	12.03-1.5x	13.57+4.3x	9.32-0.7x	10.04+6.4x	3.60-0.2x	3.82
Debt-to-Equity	0.030.0x	0.060.0x	0.090.0x	0.070.0x	0.05-0.1x	0.130.0x	0.10+0.1x	0.050.0x	0.080.0x	0.090.0x	0.070.0x	0.120.0x	0.11-0.3x	0.360.0x	0.33
Asset Turnover	0.500.0x	0.490.0x	0.480.0x	0.480.0x	0.48-0.1x	0.54-0.2x	0.71-0.1x	0.80-0.1x	0.900.0x	0.91-0.6x	1.49-0.3x	1.83-0.3x	2.16-0.2x	2.36-0.3x	2.67
FCF Margin	16.9%+6.0pp	11.0%-5.3pp	16.3%+4.5pp	11.7%+4.9pp	6.8%-8.6pp	15.4%+1.4pp	14.1%-4.7pp	18.8%+6.4pp	12.4%-8.0pp	20.5%-4.0pp	24.4%+5.7pp	18.7%+6.5pp	12.3%+9.7pp	2.5%+1.7pp	0.9%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	20.8%+3.2pp	11.5%-5.8pp	11.3%-9.3pp	12.9%+2.8pp	17.6%+5.1pp	17.3%+4.8pp	20.5%+1.4pp	10.1%-0.4pp
Net Margin	18.4%-18.5pp	12.9%-3.2pp	14.8%-3.3pp	14.1%+2.4pp	36.9%+22.9pp	16.1%+2.0pp	18.2%+0.5pp	11.7%-1.1pp
Return on Equity	2.4%-2.6pp	1.5%-1.0pp	1.8%-0.7pp	1.7%+0.2pp	5.1%+3.1pp	2.4%+0.7pp	2.5%-0.1pp	1.5%-0.2pp
Return on Assets	2.3%-2.5pp	1.4%-0.9pp	1.8%-0.6pp	1.7%+0.2pp	4.8%+3.0pp	2.3%+0.7pp	2.4%0.0pp	1.4%-0.1pp
Current Ratio	27.21+8.3x	27.58+9.0x	34.45+17.9x	29.17+13.0x	18.93+2.6x	18.55+6.9x	16.54+4.2x	16.15+1.7x
Debt-to-Equity	0.040.0x	0.040.0x	0.030.0x	0.040.0x	0.060.0x	0.060.0x	0.060.0x	0.070.0x
Asset Turnover	0.130.0x	0.110.0x	0.120.0x	0.120.0x	0.130.0x	0.140.0x	0.130.0x	0.120.0x
FCF Margin	-0.5%-26.9pp	15.2%-2.5pp	21.3%-13.5pp	1.5%+4.0pp	26.4%+36.0pp	17.7%-2.8pp	34.8%+4.1pp	-2.5%-14.1pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
PACIFIC HLTH CRE ORGZ INC PFHO	FY2025	$6.7M	$1.4M	20.7%	$12.0M	—
MARPAI INC A MRAI	FY2025	$18.1M	-$16.6M	-91.5%	$6.7M	—
PHARM-BIO SERV INC PBSV	FY2025	$9.0M	-$100K	-1.1%	$11.5M	—

Where PACIFIC HLTH CRE ORGZ INC Ranks

Frequently Asked Questions

What is PACIFIC HLTH CRE ORGZ INC's annual revenue?

PACIFIC HLTH CRE ORGZ INC (PFHO) reported $6.7M in total revenue for fiscal year 2025. This represents a 10.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PACIFIC HLTH CRE ORGZ INC's revenue growing?

PACIFIC HLTH CRE ORGZ INC (PFHO) revenue grew by 10.7% year-over-year, from $6.1M to $6.7M in fiscal year 2025.

Is PACIFIC HLTH CRE ORGZ INC profitable?

Yes, PACIFIC HLTH CRE ORGZ INC (PFHO) reported a net income of $1.4M in fiscal year 2025, with a net profit margin of 20.7%.

What is PACIFIC HLTH CRE ORGZ INC's EBITDA?

PACIFIC HLTH CRE ORGZ INC (PFHO) had EBITDA of $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is PACIFIC HLTH CRE ORGZ INC's operating margin?

PACIFIC HLTH CRE ORGZ INC (PFHO) had an operating margin of 14.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is PACIFIC HLTH CRE ORGZ INC's net profit margin?

PACIFIC HLTH CRE ORGZ INC (PFHO) had a net profit margin of 20.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is PACIFIC HLTH CRE ORGZ INC's return on equity (ROE)?

PACIFIC HLTH CRE ORGZ INC (PFHO) has a return on equity of 10.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is PACIFIC HLTH CRE ORGZ INC's free cash flow?

PACIFIC HLTH CRE ORGZ INC (PFHO) generated $1.1M in free cash flow during fiscal year 2025. This represents a 70.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is PACIFIC HLTH CRE ORGZ INC's operating cash flow?

PACIFIC HLTH CRE ORGZ INC (PFHO) generated $1.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are PACIFIC HLTH CRE ORGZ INC's total assets?

PACIFIC HLTH CRE ORGZ INC (PFHO) had $13.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are PACIFIC HLTH CRE ORGZ INC's capital expenditures?

PACIFIC HLTH CRE ORGZ INC (PFHO) invested $23K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does PACIFIC HLTH CRE ORGZ INC have outstanding?

PACIFIC HLTH CRE ORGZ INC (PFHO) had 13M shares outstanding as of fiscal year 2025.

What is PACIFIC HLTH CRE ORGZ INC's current ratio?

PACIFIC HLTH CRE ORGZ INC (PFHO) had a current ratio of 34.45 as of fiscal year 2025, which is generally considered healthy.

What is PACIFIC HLTH CRE ORGZ INC's debt-to-equity ratio?

PACIFIC HLTH CRE ORGZ INC (PFHO) had a debt-to-equity ratio of 0.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is PACIFIC HLTH CRE ORGZ INC's return on assets (ROA)?

PACIFIC HLTH CRE ORGZ INC (PFHO) had a return on assets of 10.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is PACIFIC HLTH CRE ORGZ INC's P/E ratio?

PACIFIC HLTH CRE ORGZ INC (PFHO) trades at 12.3x earnings, its market capitalization divided by net income of $979K net income, trailing 12 months to June 30, 2026. The market capitalization is $12.0M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is PACIFIC HLTH CRE ORGZ INC's price-to-sales ratio?

PACIFIC HLTH CRE ORGZ INC (PFHO) trades at 1.9x sales, its market capitalization divided by revenue of $6.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $12.0M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is PACIFIC HLTH CRE ORGZ INC's Altman Z-Score?

PACIFIC HLTH CRE ORGZ INC (PFHO) has an Altman Z-Score of 21.80, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is PACIFIC HLTH CRE ORGZ INC's Piotroski F-Score?

PACIFIC HLTH CRE ORGZ INC (PFHO) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are PACIFIC HLTH CRE ORGZ INC's earnings high quality?

PACIFIC HLTH CRE ORGZ INC (PFHO) has an earnings quality ratio of 0.84x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can PACIFIC HLTH CRE ORGZ INC cover its interest payments?

PACIFIC HLTH CRE ORGZ INC (PFHO) has an interest coverage ratio of 657.71x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.